5AM Partners IV, LLC - 16 Aug 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
10%+ Owner
Signature
5AM Partners IV, LLC, By /s/ Scott M. Rocklage, Managing Member
Issuer symbol
N/A
Transactions as of
16 Aug 2022
Net transactions value
-$660,060
Form type
4
Filing time
18 Aug 2022, 20:05:45 UTC
Previous filing
13 Apr 2022
Next filing
08 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PEARQ Class A Common Stock Sale $285,647 -160,476 -1.1% $1.78* 14,488,165 16 Aug 2022 By 5AM Ventures IV, L.P. F1
transaction PEARQ Class A Common Stock Sale $11,901 -6,686 -1.1% $1.78* 603,675 16 Aug 2022 By 5AM Co-Investors IV, L.P. F2
transaction PEARQ Class A Common Stock Sale $16,543 -9,674 -0.07% $1.71* 14,478,491 17 Aug 2022 By 5AM Ventures IV, L.P. F1
transaction PEARQ Class A Common Stock Sale $689 -403 -0.07% $1.71* 603,272 17 Aug 2022 By 5AM Co-Investors IV, L.P. F2
transaction PEARQ Class A Common Stock Sale $331,469 -213,851 -1.5% $1.55* 14,264,640 18 Aug 2022 By 5AM Ventures IV, L.P.
transaction PEARQ Class A Common Stock Sale $13,810 -8,910 -1.5% $1.55* 594,362 18 Aug 2022 By 5AM Co-Investors IV, L.P.
holding PEARQ Class A Common Stock 3,372,769 16 Aug 2022 By 5AM Opportunities I, L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F2 The shares are directly held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F3 Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein.